Pulsed-field gel electrophoresis patterns and antimicrobial susceptibility phenotypes for coagulase-positive staphylococcal isolates from pustules and carriage sites in dogs with superficial bacterial folliculitis

American Journal of Veterinary Research

Volumn 68, Issue 5, 2007, Pages 535-542

  Pinchbeck, Lauren R ^a,c   Cole, Lynette K ^a   Hillier, Andrew ^a   Kowalski, Joseph J ^a   Rajala Schultz, Pãivi J ^a   Bannerman, Tammy L ^b   York, Steven ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO DEPARTMENT OF HEALTH   (United States)

^c Asthma and Allergy Associates of South Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFALOTIN; CEFPODOXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; LINCOMYCIN; MARBOFLOXACIN; OXACILLIN; POLYMYXIN B;

ANTIBIOTIC SENSITIVITY; ANUS; ARTICLE; AXILLA; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DOG; FEMALE; FOLLICULITIS; GENOTYPE; GRAM STAINING; MALE; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; PUSTULE; SPECIES DIFFERENTIATION;

ANIMALS; ANTI-BACTERIAL AGENTS; COAGULASE; DOG DISEASES; DOGS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FOLLICULITIS; MALE; PHENOTYPE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

EID: 34249736266     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.5.535     Document Type: Article

References (53)

1. Ihrke PJ. An overview of bacterial skin diseases in the dog. Br Vet J 1987;143:112-118.
2. Pinchbeck LR, Cole LK, Hillier A, et al. Genotypic relatedness of staphylococcal strains isolated from pustules and carriage sites in dogs with superficial bacterial folliculitis. Am J Vet Res 2006;67:1337-1346.
3. Berg JN, Wendell DE, Vogelweid C, et al. identification of the major coagulase-positive Staphylococcus sp of dogs as Staphylococcus intermedius. Am J Vet Res 1984;45:1307-1309.
4. Medleau L, Long RE, Brown J, et al. Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas. Am J Vet Res 1986;47:229-231.
5. Pellerin JL, Bourdeau F, Sebbag H, et al. Epidermosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comp Immunol Microbiol Infect Dis 1998;21:115-133.
6. Biberstein EL, Jang SS, Hirsh DC. Species distribution of coagulase-positive staphylococci in animals. J Clin Microbiol 1984;19:610-615.
7. White SD, Brown AE, Chapman PL, et al. Evaluation of aerobic bacteriologic culture of epidermal collarette specimens in dogs with superficial pyoderma. J Am Vet Med Assoc 2005;226:904-908.
8. Scott DW, Miller WH, Griffin CE. Bacterial skin diseases. In: Muller and Kirk's small animal dermatology. 6th ed. Philadelphia: Saunders, 2001;274-335.
9. Scott DW, Miller WH, Griffin CE. Diagnostic methods. In: Muller and Kirk's small animal dermatology. 6th ed. Philadelphia: Saunders, 2001;125.
10. Lloyd DH, Allaker RP, Pattinson A. Carriage of Staphylococcus intermedius on the ventral abdomen of clinically normal dogs and those with pyoderma. Vet Dermatol 1991;2:161-164.
11. Harvey RG, Noble WC. Aspects of nasal, oropharyngeal and anal carriage of Staphylococcus intermedius in normal dogs and dogs with pyoderma. Vet Dermatol 1998;9:99-104.
12. Saijonmaa-Koulumies LE, Lloyd DH. Carriage of bacteria antagonistic towards Staphylococcus intermedius on canine skin and mucosal surfaces. Vet Dermatol 1995;6:187-194.
13. Harvey RG, Lloyd DH. The distribution of Staphylococcus intermedius and coagulase-negative staphylococci on the hair, skin surface, within the hair follicles and on the mucous membranes of dogs. Vet Dermatol 1994;5:75-81.
14. Devriese LA, De Pelsmaecker K. The anal region as a main carrier site of Staphylococcus intermedius and Streptococcus canis in dogs. Vet Rec 1987;121:302-303.
15. Allaker RP, Lloyd DH, Bailey RM. Population sizes and frequency of staphylococci at mucocutaneous sites on healthy dogs. Vet Rec 1992;130:303-304.
16. Bannerman TL, Hancock GA, Tenover FC, et al. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J Clin Microbiol 1995;33:551-555.
17. Sasaki A, Shimizu A, Kawano J, et al. Characteristics of Staphylococcus intermedius isolates from diseased and healthy dogs. J Vet Med Sci 2005;67:103-106.
18. Wakita Y, Shimizu A, Hajek V, eL al. Characterization of Staphylococcus intermedius from pigeons, dogs, foxes, mink, and horses by pulsed-field gel electrophoresis. J Vet Med Sci 2002;64:237-243.
19. Shimizu A, Berkhoff HA, Kloos WE, et al. Genomic DNA fingerprinting, using pulsed-field gel electrophoresis, of Staphylococcus intermedius isolated from dogs. Am J Vet Res 1996;57:1458-62.
20. Characterization of Staphylococcus intermedius from healthy dogs and cases of superficial pyoderma by DNA restriction endonuclease patterns. Vet Microbiol 1994;41:259-266.
21. Thomson RB, Miller JM. Specimen collection, transport, and processing: bacteriology. In: Murray PR, Baron EJ, JorgensenjH, et al, eds. Manual of clinical microbiology. 8th ed. Washington, DC: ASM Press, 2003;286-330.
22. Bannerman TL. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically. In: Murray PR, Jorgensen JH, et al, eds. Manual of clinical microbiology. 8th ed. Washington, DC: ASM Press, 2003;384-404.
23. Bauer AW, Kirby WM, Sherris JC, et al. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-496.
24. CLSI. Performance standards for antimicrobial disk susceptibility testing for bacteria isolated from animals; approved standard. CLSI M31-A2. 2nd ed. Wayne, Pa: Clinical and Laboratory Standards Institute, 2006.
25. CLSI. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; informational supplement. CLSI M31-Sl. Wayne, Pa: Clinical and Laboratory Standards Institute, 2006.
26. Isenberg HD. Essential procedures for clinical microbiology. Washington, DC: ASM Press, 1998;232-234.
27. Gortel K, Campbell KL, Kakoma I, et al. Methicillin resistance among staphylococci isolated from dogs. Am J Vet Res 1999;60: 1526-1530.
28. CLSI. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI M1OO-S16. Wayne, Pa: Clinical and Laboratory Standards institute, 2006.
29. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
30. Tenover FC, Arbeit R, Archer G, et al. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aurcus. J Clin Microbiol 1994;32:407-415.
31. Mickelsen PA, Plorde JJ, Gordon KP et al. Instability of antibiotic resistance in a strain of S epidermidis isolated from an outbreak of prosthetic valve endocarditis. J Infect Dis 1985;152:50-58.
32. Ganiere JP, Medaille C, Mangion C. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. J Vet Med B Infect Dis Vet Public Health 2005;52:25-31.
33. Messinger LM, Beale KM. A blinded comparison of the efficacy of daily and twice daily trimethoprim-sulfadiazine and daily sulfadimethoxine-ormetoprim therapy in the treatment of canine pyoderma. Vet Dermatol 1993;4:13-18.
34. Hartmann FA, White DG, West SEH, et al. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Vet Microbiol 2005;108:119-131.
35. Cox HU, Hoskins JD, Roy AF, et al. Antimicrobial susceptibility of coagulase-positive staphylococci isolated from Louisiana dogs. Am J Vet Res 1984;45:2039-2042.
36. Bywater RJ, Hewett GR, Marshall AB, et al. Efficacy of clavulanate-potentiated amoxycillin in experimental and clinical skin infections. Vet Rec 1985;116:177-179.
37. Peterson AD, Walker RD, Bowman MM, et al. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). J Am Anim Hosp Assoc 2002;38:407-413.
38. Pedersen K, Wegener HC. Antimicrobial susceptibility and rRNA gene restriction patterns among Staphylococcus intermedius from healthy dogs and from dogs suffering from pyoderma or otitis externa. Acta Vet Scand 1995;36:335-342.
39. Mason IS, Kietzmann M. Cephalosporins - pharmacological. basis of clinical use in veterinary dermatology. Vet Dermatol 1999;10:187-192.
40. Prescott JF, Hanna WJ, Reid-Smith R, et al. Antimicrobial drug use and resistance in dogs. Can Vet J 2002;43:107-116.
41. Carlotti DN. New trends in systemic antibiotherapy of bacterial skin disease in dogs. Compend Contin Educ Pract Vet 1996;18: 40-47.
42. Dowling PM. Antimicrobial therapy of skin and car infections. Can Vet J 1996;37:695-699.
43. Holm BR, Petersson U, Morner A, et al. Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. Vet Rec 2002;151: 600-605.
44. Oluoch AO, Weisiger R, Siegel AM, et al. Trends of bacterial skin infections in dogs: characterization of Staphylococcus intermedius isolates (1990-1992). Canine Pract 1996;21(2):12-19.
45. Noli C, Boothe D. Macrolides and lincosamides. Vet Dermatol 1999;10:217-223.
46. Harvey RG, Noble WC, Ferguson EA. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. Vet Rec 1993;132:351-353.
47. Eady EA, Ross JI, Tipper JL, et al. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother 1993;31:211-217.
48. Clarebout G, Nativelle E, Leclercq R. Unusual inducible cross resistance to macrolides, lincosamides, and streptogramins B by methylase production in clinical isolates of Staphylococcus aureus. Microb Drug Resist 2001;7:317-322.
49. Carlotti DN, Guaguere E, Pin D, et al. Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs. J Small Anim Pract 1999;40:265-270.
50. Ganiere J-P, Medaille C, Limet A, et al. Antimicrobial activity of enroffoxacin against Staphylococcus intermedius strains isolated from canine pyodermas. Vet Dermatol 2001;12:171-175,
51. Coelho-Babtista BM, Costa M, Duarte-Correia J, et al. In vitro activity of enrofloxacin, marbofloxacin, orbifloxacin, and ciprofloxacin against clinical strains of Staphylococcus intermedius isolated from dogs in Portugal. J Vet Pharmacol 2003;26:155-156.
52. Kania SA, Williamson NL, Frank LA, et al. Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma. Am J Vet Res 2004;65:1265-1268.
53. Lloyd DH, Lamport AI, Feeney C. Sensitivity to antibiotics amongst cutaneous and mucosal isolates of canine pathogenic staphylococci in the UK, 1980-1996. Vet Dermatol 1996;7:171-175.